Stay updated on M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, while the clinical trial record remains inaccessible.
    Difference
    1%
    Check dated 2026-10-25T16:20:56.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-18T22:13:01.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:12:31.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with a generic access-denied page. This indicates the page is currently inaccessible rather than an update to the study information.
    Difference
    21%
    Check dated 2026-09-20T22:29:49.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    New study documents and metadata were added to the page, including the Informed Consent Form and the Study Protocol and SAP PDFs, along with related links and MeSH terms. These additions provide expanded access to the study's documentation and context for potential participants and researchers.
    Difference
    67%
    Check dated 2026-09-13T21:53:03.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Key study documents (Informed Consent Form, Study Protocol and SAP) and several institutional references were removed from the page, reducing direct access to essential materials for the NCT03451773 trial. Context and transparency regarding collaborators and study documents are diminished.
    Difference
    21%
    Check dated 2026-09-06T22:31:19.000Z thumbnail image

Stay in the know with updates to M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 with Gemcitabine in Advanced Pancreatic Cancer Clinical Trial page.